Dilation of coronary vessels is impaired in diabetic patients when myocardial metabolic demand is increased. Deferoxamine (DFX) restores a normal dilation of epicardial coronary arteries. To assess the effects of DFX on metabolic coronary microvascular dilation in type 2 diabetic patients, coronary blood flow was measured using intracoronary Doppler and quantitative angiography in 17 type 2 diabetic patients with normal coronary arteries and without any other coronary risk factors. Measurements were made at baseline and during a cold pressor test (CPT), before and after intravenous administration of DFX. With a similar ratepressure product (RPP) increase during CPT before and after DFX (؉21.1 ؎ 8.7 vs. ؉20.5 ؎ 8.9%, respectively), coronary blood flow increase was significantly enhanced after DFX (؉31.8 ؎ 16.7 vs. ؉6.3 ؎ 12.9% before DFX, P < 0.001). Moreover, coronary resistance increased during CPT before DFX and decreased after DFX (؉14.8 ؎ 21.9 vs. ؊7.9 ؎ 10.9%, respectively, P < 0.001). Lastly, the negative relationship between coronary blood flow and RPP before DFX (R ؍ 0.546, P < 0.05) was changed in a positive relationship after DFX (R ؍ 0.518, P < 0.05). In conclusion, in type 2 diabetic patients, inhibition of iron-catalyzed oxidative reactions by DFX restored dilation of the coronary microcirculation and a normal matching between myocardial metabolic demand and coronary blood flow. Diabetes 51:813-818, 2002 R ecent studies have shown that in diabetic patients coronary blood flow is unable to match myocardial metabolic demand increase evoked by either atrial pacing or sympathetic stimulation by the cold pressor test (CPT) (1,2). It has been suggested that coronary microvascular functional abnormalities might contribute to the development of left ventricular dysfunction through episodes of silent myocardial ischemia when myocardial oxygen demand is increased and might explain the high frequency of exercise thalliumimaging defects (3-6).Impairment of dilation of the coronary microcirculation in diabetic patients has been proposed to be related to the degree of sympathetic nerve dysfunction (7). On the other hand, it is well established that oxygen-derived free radical production, which is increased in diabetes (8,9), could impair endothelium-dependent vasodilation since it has been proved that superoxide anions could inactivate nitric oxide (10). Lastly, several studies have shown that nitric oxide production was reduced in diabetes in both peripheral and coronary vascular beds (11,12).We had previously demonstrated that a low dose of deferoxamine (DFX), an iron chelator that prevents ironcatalyzed generation of hydroxyl radicals, restored normal dilation of epicardial coronary arteries in diabetic patients, suggesting that inactivation of nitric oxide by oxygen species may play a role in impairment of coronary vasomotion (13). Similar results have been obtained in peripheral circulation by antioxidant therapy (14 -17).The purpose of the present study was to determine whether impaired coronary microva...